When.com Web Search

  1. Ads

    related to: sugar blocker

Search results

  1. Results From The WOW.Com Content Network
  2. Acarbose - Wikipedia

    en.wikipedia.org/wiki/Acarbose

    Acarbose is a starch blocker. It works by inhibiting alpha glucosidase, an intestinal enzyme that releases glucose from larger carbohydrates such as starch and sucrose. It is composed of an acarviosin moiety with a maltose at the reducing terminus. It can be degraded by a number of gut bacteria. [3]

  3. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    In the sugar analogues of dapagliflozin, the β-C series are more active than α-C series so it is critical that the β-configuration is at C-1 for the inhibitory activity. [55] Both dapagliflozin and empagliflozin contain a chlorine (Cl) atom in their chemical structure. Cl is a halogen and it has a high electronegativity. This ...

  4. Glucagon (medication) - Wikipedia

    en.wikipedia.org/wiki/Glucagon_(medication)

    Glucagon, sold under the brand name Baqsimi among others, is a medication and hormone. [9] As a medication it is used to treat low blood sugar, beta blocker overdose, calcium channel blocker overdose, and those with anaphylaxis who do not improve with epinephrine. [10]

  5. Semaglutide - Wikipedia

    en.wikipedia.org/wiki/Semaglutide

    GLP-1 regulates digestion and blood sugar. The small intestine releases GLP-1 when food is eaten. It reduces hunger, signals fullness, stimulates insulin, and inhibits glucagon, maintaining glucose levels. Semaglutide is a glucagon-like peptide-1 receptor agonist. [14] [15] [16] The drug decreases blood sugar levels.

  6. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    SGLT2 inhibitors block the sodium-glucose linked transporter 2 proteins in renal tubules of nephrons in kidneys, reabsorption of glucose in into the renal tubules, promoting excretion of glucose in the urine. This causes both mild weight loss, and a mild reduction in blood sugar levels with little risk of hypoglycemia. [49]

  7. Tirzepatide - Wikipedia

    en.wikipedia.org/wiki/Tirzepatide

    At the GLP-1 receptor, though, tirzepatide shows bias towards cAMP (a messenger associated with regulation of glycogen, sugar, and lipid metabolism) generation, rather than β-arrestin recruitment. This combination of preference towards GIP receptor and distinct signaling properties at GLP-1 suggest this biased agonism increases insulin ...

  1. Ad

    related to: sugar blocker